These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19364397)

  • 21. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
    Ozeki S; Deguchi T; Yasuda M; Nakano M; Kawamura T; Nishino Y; Kawada Y
    J Clin Microbiol; 1997 Sep; 35(9):2315-9. PubMed ID: 9276409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a rapid mismatch PCR method to detect gyrA and parC mutations in ciprofloxacin-resistant clinical isolates of Escherichia coli.
    Qiang YZ; Qin T; Fu W; Cheng WP; Li YS; Yi G
    J Antimicrob Chemother; 2002 Mar; 49(3):549-52. PubMed ID: 11864958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inter- and intraquinolone predictors of antimicrobial effect in an in vitro dynamic model: new insight into a widely used concept.
    Firsov AA; Shevchenko AA; Vostrov SN; Zinner SH
    Antimicrob Agents Chemother; 1998 Mar; 42(3):659-65. PubMed ID: 9517948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Investigation of fluoroquinolone resistance mechanisms in clinical Acinetobacter baumannii isolates].
    Güler G; Eraç B
    Mikrobiyol Bul; 2016 Apr; 50(2):278-86. PubMed ID: 27175500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.
    Heisig P
    Antimicrob Agents Chemother; 1996 Apr; 40(4):879-85. PubMed ID: 8849244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of Smith's quinolone killing mechanisms during the PAE of ciprofloxacin on Escherichia coli.
    Wickens HJ; Pinney RJ
    Int J Pharm; 2001 Oct; 227(1-2):149-56. PubMed ID: 11564549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rectal E. coli above ciprofloxacin ECOFF associate with infectious complications following prostate biopsy.
    Kalalahti I; Huotari K; Lahdensuo K; Tarkka E; Santti H; Rannikko A; Pätäri-Sampo A
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1055-1060. PubMed ID: 29500572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new approach to in vitro comparisons of antibiotics in dynamic models: equivalent area under the curve/MIC breakpoints and equiefficient doses of trovafloxacin and ciprofloxacin against bacteria of similar susceptibilities.
    Firsov AA; Vostrov SN; Shevchenko AA; Portnoy YA; Zinner SH
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2841-7. PubMed ID: 9797213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications].
    González-Soltero R; García-Cañas A; Mohedano RB; Mendoza-Chamizo B; Botello E
    Rev Esp Quimioter; 2015 Jun; 28(3):139-44. PubMed ID: 26032998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The comparison of MAMA PCR and SSCP PCR to study chromosomal resistance against Ciprofloxacin and Nalidixic acid in Escherichia coli and Klebsiella pneumoniae.
    Hashemi B; Abdollahi M; Rafiei A; Pormohammad A; Ahanjan M; Moghadaszadeh M; Rashidian S
    Microb Pathog; 2018 Jul; 120():181-186. PubMed ID: 29742463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid in situ procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis.
    Santiso R; Tamayo M; Gosálvez J; Bou G; Fernández Mdel C; Fernández JL
    BMC Microbiol; 2011 Aug; 11():191. PubMed ID: 21867549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial resistance to quinolone antibiotics in Poland.
    Roliński Z; Kowalski C; Zań R; Sobol M
    J Vet Med B Infect Dis Vet Public Health; 2002 Apr; 49(3):160-2. PubMed ID: 12019949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.
    Heisig P; Tschorny R
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1284-91. PubMed ID: 8092826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of anaerobic growth on quinolone lethality with Escherichia coli.
    Malik M; Hussain S; Drlica K
    Antimicrob Agents Chemother; 2007 Jan; 51(1):28-34. PubMed ID: 17043118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High level of quinolone resistance in Escherichia coli from healthy chicken broilers.
    Kmet V; Kmetová M
    Folia Microbiol (Praha); 2010 Jan; 55(1):79-82. PubMed ID: 20336509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cooperative Behavior of Fluoroquinolone Combinations against Escherichia coli and Staphylococcus aureus.
    Vitorino GP; Becerra MC; Barrera GD; Caira MR; Mazzieri MR
    Biol Pharm Bull; 2017; 40(6):758-764. PubMed ID: 28566620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases.
    Blanche F; Cameron B; Bernard FX; Maton L; Manse B; Ferrero L; Ratet N; Lecoq C; Goniot A; Bisch D; Crouzet J
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2714-20. PubMed ID: 9124828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering the specificity of antibacterial fluoroquinolones: benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase.
    Alovero FL; Pan XS; Morris JE; Manzo RH; Fisher LM
    Antimicrob Agents Chemother; 2000 Feb; 44(2):320-5. PubMed ID: 10639357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of antibiotic resistance in Escherichia coli isolates obtained from healthy children in Spain.
    Domínguez E; Zarazaga M; Sáenz Y; Briñas L; Torres C
    Microb Drug Resist; 2002; 8(4):321-7. PubMed ID: 12523629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.